In vitro activity of BMS-181184 compared with those of fluconazole and amphotericin B against various candida spp.
We compared the in vitro activity of BMS-181184, the first compound of a new class of antifungal agents, the pradimicins, with those of fluconazole and amphotericin B against 64 clinical isolates of Candida species. MICs were determined by a microdilution method with high resolution medium for BMS-1...
Guardat en:
| Publicat a: | Antimicrob Agents Chemother |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1996
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163508/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8878616/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.40.9.2229 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|